Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resistant Ovarian Cancer

Name: Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resistant Ovarian Cancer
Published: 2025
License: Public Domain

Genmab · 2025

ClinicalTrials.gov · Datasets · License: Public Domain · 2025

Open Source ↗

ovarian-cancer

platinum-resistant ovarian cancer, antibody-drug conjugate, folate receptor alpha (frα), ovarian cancer, fallopian tube cancer, primary peritoneal cancer, folate receptor, platinum-resistant ovarian cancer (proc), rinatabart sesutecan, topoisomerase 1 inhibitor, pro1184, gen1184

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 857966
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.